谷歌浏览器插件
订阅小程序
在清言上使用

606 IMpower110: Tertiary Lymphoid Structures (TLS) and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with First-Line Atezolizumab or Chemotherapy

Regular and Young Investigator Award Abstracts(2023)

引用 0|浏览55
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要